Hypermarcas (OTCMKTS:HYPMY) Stock Price Crosses Below 50 Day Moving Average - Here's Why

Key Points

• Hypermarcas stock fell below its fifty-day moving average, trading at $4.23 despite a higher average price of $4.72.
• Scotiabank recently upgraded the company to a "strong-buy" rating, indicating positive analyst sentiment.
• The company announced a dividend of $0.0345 per share, yielding 281.0%, with the payout date set for January 8th.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report)'s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $4.72 and traded as low as $4.23. Hypermarcas shares last traded at $4.23, with a volume of 742 shares changing hands.

Wall Street Analyst Weigh In

Separately, Scotiabank raised shares of Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Strong Buy".

Hypermarcas Price Performance

The firm has a 50-day moving average of $4.68 and a 200 day moving average of $4.04. The company has a market capitalization of $2.67 billion, a PE ratio of 20.05 and a beta of 0.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, July 1st will be given a $0.0345 dividend. The ex-dividend date is Monday, June 30th. This represents a yield of 281.0%. Hypermarcas's dividend payout ratio (DPR) is presently 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.